These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15823624)

  • 1. Antithrombotic strategies for the management of non-valvular atrial fibrillation.
    Nixdorff U
    Int J Cardiol; 2005 Apr; 100(2):191-8. PubMed ID: 15823624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quick, easy, and safe? On the use of low-molecular-weight heparins in cardioversion of atrial fibrillation.
    Stellbrink C
    Eur Heart J; 2006 Dec; 27(23):2742-3. PubMed ID: 17098755
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulation in atrial fibrillation.
    Anderson M; Kirk M
    Med Health R I; 2004 Apr; 87(4):98-100. PubMed ID: 15168633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anticoagulation in cardioversion of atrial fibrillation. Current status and outlook for the future].
    Schimpf T; Stellbrink C
    Med Klin (Munich); 2003 Feb; 98(2):91-5. PubMed ID: 12601533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anticoagulation with low molecular weight heparins within the framework of cardioversion for atrial fibrillation].
    Tebbe U
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2033-6. PubMed ID: 17882745
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of atrial fibrillation and atrial flutter: Part II.
    Aronow WS
    Cardiol Rev; 2008; 16(5):230-9. PubMed ID: 18708824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New perspectives for anticoagulation in non-rheumatic atrial fibrillation: oral antithrombins].
    Scardi S; Giansante C
    Ital Heart J Suppl; 2004 Sep; 5(9):705-11. PubMed ID: 15568608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Singer DE; Albers GW; Dalen JE; Go AS; Halperin JL; Manning WJ
    Chest; 2004 Sep; 126(3 Suppl):429S-456S. PubMed ID: 15383480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombotic drugs in atrial fibrillation].
    Hidden-Lucet F
    Rev Prat; 2002 Jun; 52(12):1324-8. PubMed ID: 12187896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ximelagatran on ischemic events and death in patients with atrial fibrillation after acute myocardial infarction in the efficacy and safety of the oral direct thrombin inhibitor ximelagatran in patients with recent myocardial damage (ESTEEM) trial.
    Tangelder MJ; Frison L; Weaver D; Wilcox RG; Bylock A; Emanuelsson H; Held P; Oldgren J
    Am Heart J; 2008 Feb; 155(2):382-7. PubMed ID: 18215612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.
    O'Donnell M; Weitz JI
    Am J Manag Care; 2004 Apr; 10(3 Suppl):S72-82. PubMed ID: 15152749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Schmidt-Lucke C; Paar WD; Stellbrink C; Nixdorff U; Hofmann T; Meurer J; Grewe R; Daniel WG; Hanrath P; Mügge A; Klein HU; Schmidt-Lucke JA
    Thromb Res; 2007; 119(1):27-34. PubMed ID: 16443257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy for stroke prevention in atrial fibrillation.
    Go AS; Fang MC; Singer DE
    Prog Cardiovasc Dis; 2005; 48(2):108-24. PubMed ID: 16253651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of atrial fibrillation in the elderly.
    Aronow WS
    Minerva Med; 2009 Feb; 100(1):3-24. PubMed ID: 19182738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation.
    Bontempo LJ; Goralnick E
    Emerg Med Clin North Am; 2011 Nov; 29(4):747-58, vi. PubMed ID: 22040705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
    MMW Fortschr Med; 2006 Jun; 148(23):58-9. PubMed ID: 16826742
    [No Abstract]   [Full Text] [Related]  

  • 20. Health status outcomes after cardioversion for atrial fibrillation: results from the Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Trial.
    Elliott DJ; Zhao L; Jasper SE; Lieber EA; Klein AL; Weintraub WS
    Am Heart J; 2008 Aug; 156(2):374.e1-6. PubMed ID: 18657673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.